SCHEMBL17445847

SCHEMBL17445847

COC(=O)/C=C/CNC(=O)C(CCN)c1cccs1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.33
OPRM1 P35372 1/20 0.33
OPRK1 P41145 1/20 0.33
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
TSHR P16473 2/20 0.33
LMNA P02545 2/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
THRB P10828 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
SLC6A3 Q01959 1/20 0.33
ALOX5 P09917 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
ALOX15 P16050 1/20 0.32
CYP2C19 P33261 1/20 0.32
HPGD P15428 2/20 0.32
GLS O94925 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18905206 0.91 KDM4E (0.34) KDM4EOPRM1OPRK1TSHRLMNA
SCHEMBL17447425 0.85 KDM4E (0.36) KDM4EOPRM1OPRK1SLC6A2SLC6A4
SCHEMBL18910568 0.80 TSHR (0.38) KDM4EOPRM1OPRK1TSHRLMNA
SCHEMBL17445799 0.69 POLB (0.41) KDM4ELMNAPOLBGLSMEN1
SCHEMBL20899846 0.65 GAA (0.42) KDM4ETSHRLMNATP53POLB
SCHEMBL28085691 0.65 ALDH1A1 (0.43) KDM4ETSHRPOLBCYP2C19HPGD
SCHEMBL19826057 0.65 ALOX5 (0.34) TSHRLMNATP53POLBTHRB
SCHEMBL19826056 0.65 TSHR (0.35) TSHRLMNATP53POLBTHRB
SCHEMBL27680341 0.64 HTT (0.44) KDM4ETSHRLMNATP53POLB
SCHEMBL667372 0.63 HPGD (0.41) KDM4ETSHRTP53NPSR1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9586890-B2 Screening methods for the binding affinity of chemical entities to biological molecules and NEDD4-1 inhibitors identified by the screening methods NORTHWESTERN UNIVERSITY (US) 2017-03-07 US disclosed
US-20160016893-A1 SCREENING METHODS FOR THE BINDING AFFINITY OF CHEMICAL ENTITIES TO BIOLOGICAL MOLECULES AND NEDD4-1 INHIBITORS IDENTIFIED BY THE SCREENING METHODS NORTHWESTERN UNIVERSITY (US) 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160016893-A1 SCREENING METHODS FOR THE BINDING AFFINITY OF CHEMICAL ENTITIES TO BIOLOGICAL MOLECULES AND NEDD4-1 INHIBITORS IDENTIFIED BY THE SCREENING METHODS NEDD4, STUB1, UBQLN1 KDM4E 2809/4885OPRM1 3374/4885OPRK1 1528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.